The observed incidence of adverse reactions in patients receiving omalizumab therapy in a tertiary allergy and asthma clinic in Canada

被引：0
|
作者：
Harrison, R. [1 ]
Santucci, S. [1 ]
MacRae, M. [1 ]
Yang, W. H. [1 ,2 ]
机构：
[1] Ottawa Allergy Res Corp, Ottawa, ON, Canada
[2] Univ Ottawa, Sch Med, Ottawa, ON K1N 6N5, Canada
来源：
ALLERGY | 2015年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
845
引用
收藏
页码：350 / 351
页数：2
相关论文
共 50 条
  • [41] Incidence of adverse drug reactions in human immune deficiency virus-positive patients using highly active antiretroviral therapy
    Srikanth, B. Akshaya
    Babu, S. Chandra
    Yadav, Harlokesh Narayan
    Jain, Sunil Kumar
    JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, 2012, 3 (01) : 62 - 67
  • [42] A study on adverse drug reactions to first-line antiretroviral therapy in HIV infected patients at a tertiary care hospital in Northeast India
    Jain, Ankur
    Lihite, Ratan J.
    Lahkar, Mangala
    Baruah, Swaroop K.
    HIV & AIDS REVIEW, 2016, 15 (04): : 131 - 135
  • [43] Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology
    Carter, Melody C.
    Metcalfe, Dean D.
    Matito, Almudena
    Escribano, Luis
    Butterfield, Joseph H.
    Schwartz, Lawrence B.
    Bonadonna, Patrizia
    Zanotti, Roberta
    Triggiani, Massimo
    Castells, Mariana
    Brockow, Knut
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (03) : 880 - 893
  • [44] Incidence of anti-tuberculosis drug induced liver injuries in patients receiving therapy at a tertiary care hospital in Karachi: A cross-sectional study
    Najam, Saad
    Khan, Samia Perwaiz
    Warraich, Rizwana
    Kumar, Ajeet
    Iqbal, Nosheen
    Urooj, Syeda
    RAWAL MEDICAL JOURNAL, 2024, 49 (03): : 493 - 496
  • [45] Adverse drug reactions from highly active antiretoviral therapy among Filipino HIV/AIDS patients at the HIV/AIDS Clinic of the Philippine General Hospital
    Roman, A. D.
    Tenorio, A. R.
    Salvana, E. M.
    ANTIVIRAL THERAPY, 2011, 16 : A48 - A48
  • [46] STAT3 and STAT6 polymorphisms predict the severity of adverse reactions in Chinese NSCLC patients receiving EGFR-TKIs therapy
    Wang, Yan
    Qi, Huijie
    Wang, Tianxiao
    Zhang, Wenxin
    Shi, Xiaojin
    Zhan, Qiong
    Li, Qunyi
    Zhong, Mingkang
    JOURNAL OF CHEMOTHERAPY, 2024, 36 (01) : 61 - 71
  • [47] Incidence and predictors of sexually transmitted infections among adult HIV-positive patients receiving antiretroviral therapy at Themba Lethu HIV clinic in Johannesburg, South Africa
    Onoya, D.
    Manjengwa, P.
    Nattey, C.
    Kgowedi, S.
    Mbele, M.
    Shumba, K.
    Fox, M. P.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2021, 111 (01): : 80 - 86
  • [48] ACHIEVING NURSE READINESS IN THE ADMINISTRATION, MANAGEMENT, AND RECOGNITION OF ADVERSE REACTIONS IN PATIENTS RECEIVING CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY
    Bicknell, Pamela
    Brown, Laura
    Moreno, Kathryn
    Muniz, Paul
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [49] POOR SULFOXIDATION STATUS IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS COULD EXPLAIN THE HIGH-INCIDENCE OF ADVERSE REACTIONS TO D-PENICILLAMINE THERAPY
    OLOMU, A
    CLEMENTS, D
    WARING, R
    ELIAS, E
    GUT, 1985, 26 (05) : A561 - A561
  • [50] Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data
    Ramirez, Elena
    Urroz, Mikel
    Rodriguez, Amelia
    Gonzalez-Munoz, Miguel
    Martin-Vega, Alberto
    Villan, Yuri
    Seco, Enrique
    Monserrat, Jaime
    Frias, Jesus
    Carcas, Antonio J.
    Borobia, Alberto M.
    FRONTIERS IN PHARMACOLOGY, 2020, 11
12345